FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 227 filers reported holding FATE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,508,000 | -68.7% | 67,300 | -65.4% | 0.20% | -72.7% |
| Q2 2022 | $4,817,000 | -39.7% | 194,400 | -5.6% | 0.75% | -27.1% |
| Q1 2022 | $7,983,000 | +1650.7% | 205,900 | +2539.7% | 1.03% | +2139.1% |
| Q4 2021 | $456,000 | -26.6% | 7,800 | +14.2% | 0.05% | -43.9% |
| Q4 2020 | $621,000 | +60.1% | 6,830 | -29.7% | 0.08% | -60.2% |
| Q3 2020 | $388,000 | -65.7% | 9,712 | -70.6% | 0.21% | -68.1% |
| Q2 2020 | $1,132,000 | +407.6% | 33,000 | +189.5% | 0.64% | +200.0% |
| Q4 2019 | $223,000 | – | 11,400 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 2,073,190 | $26,599,000 | 26.59% |
| Polaris Venture Management Co. V, L.L.C. | 1,823,186 | $23,391,000 | 24.97% |
| Casdin Capital, LLC | 2,550,000 | $32,717,000 | 5.60% |
| Redmile Group, LLC | 10,359,666 | $132,915,000 | 5.34% |
| Aquilo Capital Management, LLC | 697,096 | $8,944,000 | 4.33% |
| Eversept Partners, LP | 165,000 | $2,116,950 | 1.15% |
| Artal Group S.A. | 2,150,000 | $27,585,000 | 1.02% |
| AlpInvest Partners B.V. | 26,925 | $345,000 | 0.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,654,865 | $21,232,000 | 0.85% |
| Lisanti Capital Growth, LLC | 142,760 | $1,832,000 | 0.74% |